Safety and Efficacy of Bimatoprost Solution 0.03% Topical Application in Patients with Chemotherapy-Induced Eyelash Loss

December 2013 in “ Journal of Investigative Dermatology Symposium Proceedings ”

Gurpreet S. Ahluwalia

bimatoprost chemotherapy-induced eyelash loss Global Eyelash Assessment scale conjunctival hyperemia punctate keratitis eye pruritus Latisse

TLDR Bimatoprost is safe and effective for treating eyelash loss caused by chemotherapy.

The study from December 2013 assessed the safety and efficacy of bimatoprost solution 0.03% in treating patients with eyelash loss due to chemotherapy. It involved 130 participants, with 96 receiving bimatoprost and 34 receiving a placebo. The double-masked, randomized, placebo-controlled trial lasted for one year, with 89.2% of patients completing it. After 6 months, those treated with bimatoprost showed significant improvements in eyelash growth on the Global Eyelash Assessment scale and in terms of length, thickness, and darkness, as confirmed by digital image analysis. Patients initially in the placebo group experienced similar improvements upon switching to bimatoprost from months 6 to 12. The treatment was generally well-tolerated, with the most common side effects being conjunctival hyperemia, punctate keratitis, upper respiratory tract infection, and eye pruritus. The conclusion was that bimatoprost is a safe and effective treatment for chemotherapy-induced eyelash loss.

View this study on jidsponline.org →

Discuss this study in the Community →

Research cited in this study

3 / 3 results

research Pathobiology of Chemotherapy-Induced Hair Loss

218 citations , January 2013 in “The Lancet Oncology”

Chemotherapy causes hair loss by damaging hair follicles and stem cells, with more research needed for prevention and treatment.

research Chemotherapy-Induced Alopecia: Emotional Distress and Mitigation Strategies

155 citations , March 2009 in “Seminars in Cutaneous Medicine and Surgery”

Scalp cooling might reduce hair loss from chemotherapy, but evidence is weak and other treatments are being tested.

research Skin Toxicity of Anti-Cancer Therapy

19 citations , October 2008 in “Journal der Deutschen Dermatologischen Gesellschaft”

Anti-cancer treatments can cause reversible hair loss, skin sensitivity, pigmentation changes, nail damage, and skin reactions, with a need for more research on managing these side effects.

Related Community Posts Join

6 / 113 results

community 18->24 six years of Fin and Minox…. I guess we can’t all be winners 😭

in Progress Pictures 572 upvotes 3 years ago

A user named "EgyptStar81" who has been dealing with hair loss since age 15 due to genetics, chemotherapy and finasteride/minoxidil treatment. Possible solutions such as dutasteride, oral minoxidil, hair transplants and extensions were suggested.

community Medications that cause extra hair growth

in Research/Science 123 upvotes 2 years ago

The post discusses the side effects of various drugs causing excess hair growth, questioning why only minoxidil is used in the hair loss industry. The conversation includes users sharing their experiences and concerns about potential side effects of these drugs, with some preferring baldness over potential health risks.

community 25M: Regrowth Chances After 5 Years on Minoxidil Alone Now Adding Finasteride and Others?

Kujodo in General 64 upvotes 5 months ago

The user used minoxidil alone for 5 years and recently added finasteride, ketoconazole shampoo, bimatoprost, and dermarolling to their routine. They are hopeful for regrowth, as combining these treatments can address hair loss causes, but results may take up to a year.

community Thoughts on Latanoprost For Miniturization?

in Treatment 3 upvotes 2 years ago

User discusses Latanoprost as potential hair loss treatment and considers combining it with oral minoxidil for better results. Seeking opinions on effectiveness and expense.

community Latanoprost from the gray market?

in Chat 4 upvotes 1 year ago

The conversation discusses sourcing pure latanoprost from the gray market for research and making a homemade solution. Concerns about potential dangers and experiences with this method are raised.

community Any New Findings or Interesting Research?

in Research/Science 25 upvotes 2 years ago

The conversation is about seeking new research on hair loss treatments beyond the commonly known ones like Minoxidil and Finasteride. Additions to the list of treatments include topical caffeine, alfatradiol, fluridil, stemoxydine, and upcoming treatments like TDM-105795 and verteporfin.

Related Research

9 / 9 results

research Baricitinib Results in Eyebrow and Eyelash Growth in Patients With Alopecia Areata Who Do Not Achieve 20% or Less Scalp Hair Loss

1 citations , September 2022 in “Journal of The American Academy of Dermatology”

Baricitinib helps grow eyebrows and eyelashes in severe alopecia areata patients.

research Bimatoprost for the Treatment of Eyelash, Eyebrow, and Scalp Alopecia

38 citations , March 2017 in “Expert Opinion on Investigational Drugs”

Bimatoprost is promising for treating some types of hair loss but needs more testing for androgenetic alopecia.

research Bimatoprost Solution 0.03% Topical Application to the Eyelid Margin for the Treatment of Eyelash Hypotrichosis

2 citations , February 2016 in “British Journal of Dermatology”

Bimatoprost solution 0.03% is effective for treating sparse eyelashes.

Long-Term Safety and Efficacy of Bimatoprost Solution 0.03% Application to the Eyelid Margin for the Treatment of Idiopathic and Chemotherapy-Induced Eyelash Hypotrichosis: A Randomized Controlled Trial

research Long-Term Safety and Efficacy of Bimatoprost Solution 0.03% Application to the Eyelid Margin for the Treatment of Idiopathic and Chemotherapy-Induced Eyelash Hypotrichosis: A Randomized Controlled Trial

38 citations , October 2014 in “British journal of dermatology/British journal of dermatology, Supplement”

Bimatoprost solution is effective and safe for long-term use in treating eyelash thinning.

research The Prostamide-Related Glaucoma Therapy, Bimatoprost, Offers a Novel Approach for Treating Scalp Alopecias

53 citations , October 2012 in “The FASEB Journal”

Bimatoprost, a glaucoma medication, may also help treat hair loss.

Long-Term Safety and Efficacy of Latisse (Bimatoprost 0.03% Solution) for Treatment of Eyelash Hypotrichosis in Subjects with Chemotherapy-Induced and Idiopathic Hypotrichosis

research Long-Term Safety and Efficacy of Latisse (Bimatoprost 0.03% Solution) for Treatment of Eyelash Hypotrichosis in Subjects with Chemotherapy-Induced and Idiopathic Hypotrichosis

March 2012 in “Journal of The American Academy of Dermatology”

Latisse is safe and effective for long-term eyelash growth in people with thin eyelashes from chemotherapy or unknown causes.